Cargando…

Does CHA2DS2-VASc score predict mortality in chronic kidney disease?

Chronic kidney disease (CKD) is a leading cause of morbidity and mortality worldwide. Assessment of cardiovascular (CV) and all-cause mortality in CKD patients is of particular importance. CHA2DS2-VASc (congestive heart failure, hypertension, age ≥ 75 years, diabetes, prior stroke, vascular disease,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goudis, Christos, Daios, Stylianos, Korantzopoulos, Panagiotis, Liu, Tong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	IM-Point of view
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261034/ https://www.ncbi.nlm.nih.gov/pubmed/34232486 http://dx.doi.org/10.1007/s11739-021-02799-5

Ejemplares similares

Mortality prediction using a modified R(2)CHA(2)DS(2)-VASc score among hospitalized COVID-19 patients
por: Levy, David, et al.
Publicado: (2022)

Prognostic role of CHA(2)DS(2)-VASc score for mortality risk assessment in non-advanced idiopathic pulmonary fibrosis: a preliminary observation
por: Sonaglioni, Andrea, et al.
Publicado: (2023)

CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022)

CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients
por: Gunduz, Ramazan, et al.
Publicado: (2021)

CHA(2)DS(2)-VASc and R(2)-CHA(2)DS(2)-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2018)

CHA(2)DS(2)-Vasc score and CHA(2)DS(2)-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents
por: Zhao, Sheng Gang, et al.
Publicado: (2019)

CHA(2)DS(2)-VASc Score in Cardio-Oncology: Sharpening the Rules
por: López-Fernández, Teresa
Publicado: (2023)

Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score
por: Bungo, Brandon, et al.
Publicado: (2022)

Using CHADS(2) and CHA(2)DS(2)-VASc scores for mortality prediction in patients with chronic kidney disease
por: Hsu, Po-Chao, et al.
Publicado: (2020)

Cheating the CHA(2)DS(2)-VASc Score: Thromboembolism in Apical Hypertrophic Cardiomyopathy
por: Weir, Robin A. P., et al.
Publicado: (2014)

Correlation between CHA(2)DS(2)-VASc Score and Glaucoma Treatment and Prognosis
por: Pikkel, Yoav Y., et al.
Publicado: (2018)

SARS-CoV-2 and myocardial injury: a role for Nox2?
por: Violi, Francesco, et al.
Publicado: (2020)

CHA(2)DS(2)‐VASc Score and the Risk of Ventricular Tachyarrhythmic Events and Mortality in MADIT‐CRT
por: Nof, Eyal, et al.
Publicado: (2019)

CHA(2)DS(2)-VASc score stratifies mortality risk in patients with and without atrial fibrillation
por: Harb, Serge C, et al.
Publicado: (2021)

Predictive value of CHA(2)DS(2)-VASc and CHA(2)DS(2)-VASc-HS scores for failed reperfusion after thrombolytic therapy in patients with ST-segment elevation myocardial infarction
por: Kilic, Salih, et al.
Publicado: (2019)

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies
por: Albini, Adriana, et al.
Publicado: (2020)

Type 2 myocardial infarction: a diagnostic and therapeutic challenge in contemporary cardiology
por: Merlo, Andrea Carlo, et al.
Publicado: (2022)

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
por: Testa, Sophie, et al.
Publicado: (2020)

Value of the CHA(2)DS(2)‐VASc score for predicting outcome in patients with heart failure
por: Shuvy, Mony, et al.
Publicado: (2020)

Stroke and systemic embolism risk in patients with CHA(2)DS(2)‐VASc score of 0
por: Babayiğit, Erdi, et al.
Publicado: (2023)

Aerosol delivery systems for treating obstructive airway diseases during the SARS-CoV-2 pandemic
por: Lavorini, Federico, et al.
Publicado: (2021)

Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines
por: Marcucci, Rossella, et al.
Publicado: (2021)

The CHA(2)DS(2)‐VASc score as a predictor of high mortality in hospitalized heart failure patients
por: Yoshihisa, Akiomi, et al.
Publicado: (2016)

One-Year Mortality after Hemodialysis Initiation: The Prognostic Role of the CHA(2)DS(2)-VASc Score
por: Abrantes, Ana Mafalda, et al.
Publicado: (2023)

Predictive Value of the CHA(2)DS(2)-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease
por: Wu, Yaxin, et al.
Publicado: (2022)

Prognostic Impacts of CHADS(2), CHA(2)DS(2)-VASc, and CHA(2)DS(2)-VASc-HS Scores on Clinical Outcomes After Elective Drug-Eluting Stent Placement for De Novo Coronary Stenosis
por: Ukaji, Tomoaki, et al.
Publicado: (2023)

High CHA(2)DS(2)-VASc score without atrial fibrillation: ‘NAO yes, NAO no’
por: Perna, Gian Piero
Publicado: (2019)

What should the C (‘congestive heart failure’) represent in the CHA(2)DS(2)‐VASc score?
por: Mulder, Bart A., et al.
Publicado: (2020)

Predictive Value of CHA(2)DS(2) -VASc-HSF Score for Severity of Acute Coronary Syndrome
por: Liu, Jingyi, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc score for in-hospital recurrence risk stratification in patients with myocardial infarction
por: Pang, Hui, et al.
Publicado: (2022)

Heart failure: a weak link in CHA(2)DS(2)‐VASc
por: Friberg, Leif, et al.
Publicado: (2018)

Mortality Prediction of the CHA(2)DS(2)-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation
por: Morrone, Doralisa, et al.
Publicado: (2020)

Assessment of the Modified CHA2DS2VASc Risk Score in Predicting Mortality in Patients Hospitalized With COVID-19
por: Cetinkal, Gokhan, et al.
Publicado: (2020)

Impact of timing of atrial fibrillation, CHA(2)DS(2)-VASc score and cancer therapeutics on mortality in oncology patients
por: Hussain, Muzna, et al.
Publicado: (2020)

Arterial Thromboembolism in Patients With AF and CHA(2)DS(2)-VASc Score 0-2 With and Without Cancer
por: Leader, Avi, et al.
Publicado: (2023)

Potential role of incretins in diabetes and COVID-19 infection: a hypothesis worth exploring
por: Pantanetti, Paola, et al.
Publicado: (2020)

COVID-19: The crucial role of blood coagulation and fibrinolysis
por: Coccheri, Sergio
Publicado: (2020)

Thrombosis centres and AVKs monitoring in COVID-19 pandemic
por: Barcellona, Doris, et al.
Publicado: (2020)

Treat all COVID 19-positive patients, but do not forget those negative with chronic diseases
por: Mauro, Viganò, et al.
Publicado: (2020)

Flowchart for non-invasive ventilation support in COVID-19 patients from a northern Italy Emergency Department
por: Privitera, Daniele, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ummk7fcne0258ien970at34g7g